FDA
-
-
-
-
-
-
-
Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results
-
-
-
-
-
-
-
Titan's Probuphine® Commercialization Partner, Molteni, Enters Into Exclusive European Distribution Agreement With Accord Healthcare
-
-
-
-
-
-
-
Titan Pharma (TTNP) And Indegene Enter Into Probuphine Co-Promotion Partnership
-
-
-
-
-
-
-
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020
-
-
-
-
-
-
-
Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors
-
-
-
-
-
-
-
Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facilities
-
-
-
-
-
-
-
Titan Pharma (TTNP) Expands Patient Access to Probuphine Via Specialty Product Distribution Agreement With CVS Caremark
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

